OGN vs RF
Organon & Co (OGN) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
RF (RF) common stock.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
RF does not have a complete income-statement cache yet.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. RF currently screens at market cap $0.
Not investment advice. Open the OGN and RF stock pages for the full models.
Not investment advice.